Jose Rubio

19PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersChild and adolescent developmentClinical pharmacology and therapeuticsInnate immunityClinical neuropsychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 04, 2026
Absolute Receptor Occupancy, Not Rate of Decline, Predicts Relapse.

|May 09, 2026
Persistent Psychosis During 4 Years after First Hospitalization for a Psychotic Disorder in the Suffolk County Mental Health Project: Prevalence, Risk Factors, and Relationship to 25-Year Outcomes.

|Mar 25, 2026
The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.

Joseph F Goldberg, Holly A Swartz, Roger S McIntyre

|Feb 06, 2026
The Relationship between Baseline Neutrophils Counts and Response to 12 Weeks of Antipsychotics in First-Episode Psychosis.

Gauri Shastri, Jose Rubio, Juan Gallego

|Dec 17, 2025
Benefits and risks of antipsychotic discontinuation in people with first and multi-episode psychotic disorders or with schizophrenia: why, when, how and in whom?

Christoph U Correll, Jose M Rubio, John M Kane

|Nov 07, 2025
Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophrenia.

Ryosuke Tarumi, Shiori Honda, Clifford Cassidy

Pageof 4

Frequent Collaborators

6 joint publications

John M Kane

4 joint publications

Deepak Sarpal

4 joint publications

Christoph U Correll

3 joint publications

Juan Gallego